GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in GH Research PLC as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +34 vs. Q1 2021
- Shares held
- 27.6M
- +27.6M vs. Q1 2021
- Total value
- $593.7M
- +$593.7M vs. Q1 2021
- New holders
- 34
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 63 | $1.38B |
| Q1 2026 | 54 | $668.5M |
| Q4 2025 | 53 | $591.4M |
| Q3 2025 | 47 | $618.1M |
| Q2 2025 | 38 | $530.9M |
| Q1 2025 | 36 | $470.1M |
| Q4 2024 | 31 | $214.9M |
| Q3 2024 | 28 | $204.2M |
| Q2 2024 | 28 | $354.8M |
| Q1 2024 | 32 | $315.5M |
| Q4 2023 | 35 | $171.7M |
| Q3 2023 | 29 | $291.5M |
| Q2 2023 | 34 | $351.6M |
| Q1 2023 | 29 | $237.2M |
| Q4 2022 | 32 | $299.5M |
| Q3 2022 | 34 | $367.2M |
| Q2 2022 | 35 | $325.0M |
| Q1 2022 | 33 | $587.1M |
| Q4 2021 | 30 | $701.0M |
| Q3 2021 | 30 | $625.2M |
| Q2 2021 | 34 | $593.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding GH Research PLC; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 335 | $7.00K | 0.00% | +335 | New |
| Tower Research Capital LLC (TRC) | 837 | $18.0K | 0.00% | +837 | New |
| BlackRock Inc. | 1,000 | $21.0K | 0.00% | +1,000 | New |
| Capstone Investment Advisors, LLC | 10,000 | $217.0K | 0.01% | +10,000 | New |
| Qube Research & Technologies Ltd | 17,525 | $381.0K | 0.00% | +17,525 | New |
| Squarepoint Ops LLC | 18,000 | $391.0K | 0.00% | +18,000 | New |
| Polar Asset Management Partners Inc. | 19,624 | $426.0K | 0.01% | +19,624 | New |
| Millennium Management LLC | 45,866 | $997.0K | 0.00% | +45,866 | New |
| Pinz Capital Management, LP | 68,500 | $1.49M | 0.45% | +68,500 | New |
| Walleye Capital LLC | 85,100 | $1.85M | 0.07% | +85,100 | New |
| Alyeska Investment Group, L.P. | 100,000 | $2.17M | 0.03% | +100,000 | New |
| Maven Securities LTD | 100,000 | $2.17M | 0.23% | +100,000 | New |
| Woodline Partners LP | 138,897 | $3.02M | 0.06% | +138,897 | New |
| Acuta Capital Partners, LLC | 150,000 | $3.26M | 1.40% | +150,000 | New |
| Monashee Investment Management LLC | 165,000 | $3.58M | 0.43% | +165,000 | New |
| Morgan Stanley | 201,728 | $4.38M | 0.00% | +201,728 | New |
| HealthCor Management, L.P. | 250,000 | $5.43M | 0.22% | +250,000 | New |
| Laurion Capital Management LP | 360,000 | $7.82M | 0.12% | +360,000 | New |
| Pura Vida Investments, LLC | 400,000 | $8.69M | 0.62% | +400,000 | New |
| TimesSquare Capital Management, LLC | 422,289 | $9.18M | 0.08% | +422,289 | New |
| Adage Capital Partners GP, L.L.C. | 465,000 | $10.1M | 0.02% | +465,000 | New |
| Deerfield Management Company, L.P. (Series C) | 555,416 | $12.1M | 0.21% | +555,416 | New |
| Avidity Partners Management LP | 560,000 | $12.2M | 0.33% | +560,000 | New |
| Cormorant Asset Management, LP | 608,123 | $12.6M | 0.49% | +608,123 | New |
| Logos Global Management LP | 724,333 | $15.7M | 1.35% | +724,333 | New |
| Boxer Capital, LLC | 1,013,399 | $22.0M | 0.78% | +1,013,399 | New |
| Citadel Advisors LLC | 1,283,790 | $27.1M | 0.03% | +1,283,790 | New |
| VR Adviser, LLC | 1,275,831 | $27.7M | 3.36% | +1,275,831 | New |
| Verition Fund Management LLC | 1,338,124 | $29.1M | 0.43% | +1,338,124 | New |
| FMR LLC | 1,361,694 | $29.6M | 0.00% | +1,361,694 | New |
| OrbiMed Advisors LLC | 1,428,666 | $31.0M | 0.32% | +1,428,666 | New |
| RTW Investments, LP | 2,168,957 | $42.7M | 0.64% | +2,168,957 | New |
| Ra Capital Management, L.P. | 2,978,955 | $64.7M | 1.04% | +2,978,955 | New |
| BVF Inc | 9,275,156 | $201.5M | 7.55% | +9,275,156 | New |